All In Biotech

Drug Trial Radar · NCT05181137

A Phase 3 Study to Investigate the Efficacy and Safety of SHR0302 With Moderately to Severely Active Ulcerative Colitis

A Phase 3 Study to Evaluate the Efficacy and Long-term Safety of SHR0302 Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis

Last checked: Nov 19, 2026Latest source record: Sep 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 368 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

368

Planned (sponsor's estimate)

Start

Nov 5, 2021

Primary completion

Oct 31, 2024

Study completion Mar 31, 2025

Sponsor

Sponsor type
Industry
First posted
Jan 6, 2022

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, double-blind, placebo-controlled, multicenter Phase 3 study that will enroll approximately 368 subjects aged 18 to 75 years old with Moderately to Severely Active Ulcerative Colitis.

Conditions

  • Ulcerative Colitis

Interventions

  • SHR0302Drug

    Oral tablets taken once daily (QD)

  • PlaceboDrug

    Oral tablets taken once daily (QD)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical remission at week 8 (Part 1)Time frame: 8 weeks
  2. Clinical remission at week 52 (Part 2)Time frame: 52 weeks

Locations

113 sites in 5 countries. Site status is shown where the registry gives one.

  • Digestive Health Specialists

    Dothan, Alabama · Completed

  • Om Research LLC

    Lancaster, California · Terminated

  • Yale University

    New Haven, Connecticut · Terminated

  • IHS Health

    Kissimmee, Florida · Active not recruiting

  • Dade Research Center

    Miami, Florida · Terminated

  • Gastro Florida

    Pinellas Park, Florida · Completed

  • One Health Research Clinic Atlanta, LLC

    Norcross, Georgia · Active not recruiting

  • John Hopkins University

    Columbia, Maryland · Terminated

  • Michigan Medical

    Ann Arbor, Michigan · Terminated

  • Research Institute of Michigan

    Chesterfield, Michigan · Withdrawn

  • NY Scientific

    Brooklyn, New York · Terminated

  • DiGiovanna Institute for Medical Education & Research

    North Massapequa, New York · Terminated

  • University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina · Terminated

  • Charlotte Gastroenterology & Hepatology P.L.L.C

    Charlotte, North Carolina · Withdrawn

  • DDSI

    Oklahoma City, Oklahoma · Withdrawn

  • Central Sooner Research

    Oklahoma City, Oklahoma · Terminated

  • Vanderbilt University Medical Center

    Nashville, Tennessee · Terminated

  • Omni Clinical Research

    Houston, Texas · Terminated

  • UTMB Health

    League City, Texas · Terminated

  • University of Utah

    Salt Lake City, Utah · Terminated

  • McGuire Research Institute

    Richmond, Virginia · Terminated

  • IACT Health

    Suffolk, Virginia · Withdrawn

  • Advocate Aurora Health - Aurora St. Luke's Medical Center

    Milwaukee, Wisconsin · Terminated

  • The First Affiliated Hospital of Bengbu Medical College

    Bengbu, Anhui, China · Recruiting

  • Anhui Provincial Hospital

    Hefei, Anhui, China · Recruiting

  • Beijing Military Area General Hospital/Seventh Medical Center of PLA General Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Peking University First Hospital

    Beijing, Beijing Municipality, China · Terminated

  • Peking University Third Hospital

    Beijing, Beijing Municipality, China · Recruiting

  • Tsinghua University Changgung Hospital

    Beijing, Beijing Municipality, China · Not yet recruiting

  • Army Medical Center of PLA

    Chongqing, Chongqing Municipality, China · Recruiting

  • Chongqing People's Hospital

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing Municipality, China · Recruiting

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, China · Recruiting

  • The First Affiliated Hospitial of Xiamen University

    Xiamen, Fujian, China · Recruiting

  • Guangzhou First People's Hospital

    Guangzhou, Guangdong, China · Recruiting

  • The First Affiliated Hospital, Sun Yat-sen University

    Guangzhou, Guangdong, China · Recruiting

  • The Sixth Affiliated Hospital of Sun Yat-Sen University

    Guangzhou, Guangdong, China · Recruiting

  • Third Affiliated Hospital of Guangzhou Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Peking University Shenzhen Hospital

    Shenzhen, Guangdong, China · Recruiting

  • The First Affiliated Hospital of Guangxi Medical University

    Nanning, Guangxi, China · Recruiting

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.